Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses
Research and development	$ 11,296	$ 13,297	$ 21,594	$ 23,102
General and administrative	4,697	4,530	9,471	8,672
Total operating expenses	15,993	17,827	31,065	31,774
Loss from operations	(15,993)	(17,827)	(31,065)	(31,774)
Interest income	1,450	1,436	2,836	2,532
Change in fair value of earnout liability		420	(20)	(344)
Change in fair value of common stock warrant liability				(575)
Other expense, net	(40)	(109)	(62)	(179)
Total other income, net	1,410	1,747	2,754	1,434
Net loss and comprehensive loss	$ (14,583)	$ (16,080)	$ (28,311)	$ (30,340)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.97)	$ (1.47)	$ (2)	$ (3.08)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)	14,986,367	10,921,239	14,160,634	9,860,392